APA aipamena

Nakade, J., Takeuchi, S., Nakagawa, T., Ishikawa, D., Sano, T., Nanjo, S., . . . Yano, S. (2014). Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation. Lippincott Williams & Wilkins.

Chicago Style aipamena

Nakade, Junya, et al. Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation. Lippincott Williams & Wilkins, 2014.

MLA aipamena

Nakade, Junya, et al. Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation. Lippincott Williams & Wilkins, 2014.